Dan Rubin

United States Food and Drug Administration

Business, Management and AccountingSocial SciencesPsychology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia”.

Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

Clinical Infectious Diseases(2023)10.1093/cid/ciad576

N/A

0DataRank · unranked

18 citations

Toshimitsu Hamasaki, Weixiao Dai, Deborah Collyar, Daniel B. Rubin, Sumathi Nambiar +24 more

US Food and Drug Administration, Centers for Disease Control and Prevention, and National Institutes of Health Co-Sponsored Public Workshop Summary—Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea

Clinical Infectious Diseases(2024)10.1093/cid/ciae386

N/A

0DataRank · unranked

6 citations

Shukal Bala, James M. Byrne, Kerian Grande Roche, Seong H. Jang, Peter Kim +30 more